A major metabolite of estrone
Estrogens and Metabolites (Urine) - DUTCH
Estrogen is a key anabolic hormone, meaning it promotes growth and development in the body.
There are three primary forms of estrogen:
-
Estrone (E1) – weaker, but still biologically active
-
Estradiol (E2) – the most potent and biologically active form, responsible for most estrogen effects
-
Estriol (E3) – weaker, plays a bigger role in vaginal and urinary tract health
Where Is Estrogen Made?
-
In Women:
-
In premenopausal women, most estrogen is produced in the ovaries.
-
Smaller amounts are created by converting testosterone into estrogen through a process called aromatization.
-
After menopause, estrogen production shifts almost entirely to aromatization.
-
The enzyme responsible for aromatization is found in fat tissue, the brain, gonads, blood vessels, skin, and bone.
-
-
In Men:
-
Men produce estrogen mainly through aromatization of testosterone.
-
Men’s estrogen levels are much lower than those of cycling women—but interestingly, men often have higher estrogen levels than postmenopausal women.
-
What Does Estrogen Do?
Estrogen plays a role in multiple systems of the body:
-
Reproductive health:
-
Supports the growth of female secondary sex characteristics
-
Thickens the uterine lining for implantation
-
Increases vaginal acidity (protects against infection)
-
Maintains vaginal lubrication (E3 is especially important here)
-
-
Bone health: Maintains bone density and strength
-
Brain function:
-
Helps regulate body temperature
-
Protects against memory decline
-
Increases serotonin and serotonin receptors
-
-
Skin and connective tissue:
-
Supports collagen production
-
Maintains skin thickness
-
Improves blood flow to the skin
-
-
Cardiovascular protection: Helps protect against atherosclerosis
What Is a Metabolite?
When your body makes estrogen, it eventually needs to break it down and eliminate it.
This happens in the liver through phase 1 and phase 2 detoxification, producing intermediate forms called metabolites.
Phase 1 Estrogen Metabolism
In phase 1, estrone (E1) and estradiol (E2) are converted into three main metabolites:
-
2-OH-E1 – considered the “safer” metabolite; weakly stimulates cell growth and may even help inhibit it
-
4-OH-E1 – can damage DNA; linked to higher cancer risk
-
16-OH-E1 – more estrogenic; can contribute to symptoms of estrogen dominance
Typical healthy distribution of phase 1 metabolites:
-
70% → 2-OH-E1
-
10% → 4-OH-E1
-
20% → 16-OH-E1
Unbalanced ratios—especially high 4-OH-E1—may increase health risks in both men and women.
Phase 2 Estrogen Metabolism (Methylation)
After phase 1, metabolites move into phase 2 detoxification, specifically methylation.
Methylation neutralizes the potentially harmful phase 1 metabolites, preparing them for safe elimination instead of allowing them to recirculate in the body.
-
Only 2-OH and 4-OH metabolites can be methylated.
-
16-OH-E1 is not methylated and is eliminated through other pathways.
Why This Matters in the DUTCH Test
By measuring estrogens and their metabolites, the DUTCH test can:
-
Assess overall estrogen production
-
Determine how your body is processing estrogen through phase 1 and phase 2 detoxification
-
Identify unfavorable metabolism patterns that may contribute to symptoms or long-term health risks
-
Guide targeted support for liver detoxification and hormone balance
Biomarkers in this category
22 biomarkers · optimal ranges shown
A major metabolite of estrone
The 2-Methoxy Estrogens are considered to be protective.
The 2-Methoxy Estrogens are considered to be protective.
The 2-Methoxy Estrogens are considered to be protective.
The 2-Methoxy Estrogens are considered to be protective.
2-Hydroxyestrone is an endogenous biomarker and major urinary metabolite of estrone and estradiol.
2-Hydroxyestrone is an endogenous biomarker and major urinary metabolite of estrone and estradiol.
Research and clinical studies show that the 2-hydroxylated estrogens (2-OH E2 and 2-OH E1) are a safer pathway of hydroxylation than the 4-hydroxyestrogens (4-OH E2 and 4-OH E1), which bind to and damage DNA, leading to mutations that are associated with increased breast cancer risk. If either 4-OH-E2 or 4-OH-E1 are higher than reference range, and not well methylated, this may indicate higher risk for DNA damage, mutations, and risk for developing breast cancer. Hydroxylation of estrogens in the 2-position of estradiol (2-OH-E2) and estrone (2-OH-E1) is considered a safer pathway for metabolism than the 4-position hydroxylations of these estrogens. The 2-position hydroxylations (considered safer) are increased with cruciferous vegetables (and extracts of them) as well as iodine. The most commonly used are indole-3-carbinol (I3C) and its metabolite diindolylmethane (DIM). Iodine also increases the 2-hydroxylation of estrogens, with a slight increase in 4-hydroxylation. The more dangerous 4-hydroxylated estrogen metabolism is enhanced by exposure to environmental toxins, mostly petrochemical-based products but also heavy metals, that induce 4-hydroxylation pathway enzymes, and cause formation of Reactive Oxygen Species (ROS) that co-oxidize the catechol estrogens to more dangerous estrogen quinones.
Research and clinical studies show that the 2-hydroxylated estrogens (2-OH E2 and 2-OH E1) are a safer pathway of hydroxylation than the 4-hydroxyestrogens (4-OH E2 and 4-OH E1), which bind to and damage DNA, leading to mutations that are associated with increased breast cancer risk. If either 4-OH-E2 or 4-OH-E1 are higher than reference range, and not well methylated, this may indicate higher risk for DNA damage, mutations, and risk for developing breast cancer. Hydroxylation of estrogens in the 2-position of estradiol (2-OH-E2) and estrone (2-OH-E1) is considered a safer pathway for metabolism than the 4-position hydroxylations of these estrogens. The 2-position hydroxylations (considered safer) are increased with cruciferous vegetables (and extracts of them) as well as iodine. The most commonly used are indole-3-carbinol (I3C) and its metabolite diindolylmethane (DIM). Iodine also increases the 2-hydroxylation of estrogens, with a slight increase in 4-hydroxylation. The more dangerous 4-hydroxylated estrogen metabolism is enhanced by exposure to environmental toxins, mostly petrochemical-based products but also heavy metals, that induce 4-hydroxylation pathway enzymes, and cause formation of Reactive Oxygen Species (ROS) that co-oxidize the catechol estrogens to more dangerous estrogen quinones.
A very carcinogenic estrogen metabolite, levels low in the reference range are desirable. Additional magnesium, liver support, and methylation support may help decrease 4-OH-E1 levels.
A very carcinogenic estrogen metabolite, levels low in the reference range are desirable. Additional magnesium, liver support, and methylation support may help decrease 4-OH-E1 levels.
4-OH-E2 may increase the risk of estrogen-sensitive cancers.
4-OH-E2 may increase risk of estrogen-sensitive cancers.
Estradiol (Estrogen) is a female hormone, produced primarily in the ovary.
Estradiol (Estrogen) is a female hormone, produced primarily in the ovary.
Has weak estrogen activity.
Has weak estrogen activity.
Estrogen metabolite
Estrogen metabolite
Female hormone
Female hormone